Form 4: DaVita Director Phyllis Yale Acquires 411 Shares

DaVita Inc. Director Phyllis R. Yale reported the acquisition of 411 shares of common stock on November 15, 2025, as part of a pre-planned transaction.

Summary

• Phyllis R. Yale, a Director of DaVita Inc. (DVA), acquired 411 shares of common stock.
• The transaction occurred on November 15, 2025.
• The acquisition price was $0 per share, indicating a grant or award rather than a market purchase.
• Following this transaction, Ms. Yale beneficially owns 13,981 shares of DaVita Inc. common stock.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating it was pre-scheduled.

Sentiment

Score: 7

Explanation: The acquisition of shares by a director, even if a grant, generally indicates alignment of interests and confidence in the company's future, contributing to a moderately positive sentiment.

Positives

• An insider (Director) is increasing their beneficial ownership in the company, which can be seen as a sign of confidence.
• The transaction was pre-planned under a Rule 10b5-1(c) plan, indicating a structured approach to equity compensation or investment.

Future Outlook

NA

Industry Context

This is a routine insider transaction for a healthcare services company specializing in kidney care. Such transactions are common for directors receiving equity compensation as part of their board service.

Stakeholder Impact

• Shareholders: Increased insider ownership may be viewed positively, signaling confidence in the company's future performance and alignment of interests with shareholders.

Key Dates

Recommendation

This Form 4 reports a routine acquisition of shares by a director, likely as part of compensation. While insider buying can be a positive signal, this specific transaction (411 shares at $0 price) is not substantial enough to warrant a change in investment recommendation based solely on this filing. It primarily indicates ongoing director compensation and alignment.

Keywords

DaVita Inc., DVA, Phyllis R. Yale, Insider Trading, Form 4, Stock Acquisition, Director, Beneficial Ownership, Equity Compensation, Rule 10b5-1